Devil’s Claw

Supplements · Joint Health · Supplement, Typed Supps

A southern African root studied for joint and back pain — but only tested for a few weeks at a time.

Stage by stage

Intake (Extract capsule): Active harpagoside compound absorbed in the small intestine.
Small intestine (Absorbed): Absorbed alongside other plant compounds.
Bloodstream (Circulates): Circulates with anti-inflammatory activity.
Joint tissue (Studied comfort effect): Studied for modest effects on joint discomfort, generally with several weeks of consistent use.

What the evidence supports

Easing pain in osteoarthritis of the hip, knee and spine — moderate evidence. Systematic reviews of extracts standardised to harpagoside show short-term pain relief better than placebo, though most trials were small and ran only up to about six weeks.
Relieving acute flare-ups of chronic low back pain — moderate evidence. A Cochrane review found an aqueous extract delivering 50 mg harpagoside daily beat placebo for short-term pain and reduced rescue-medication use.
Evidence on Safety and benefit beyond about six weeks — insufficient evidence. Trials almost never ran longer than six weeks, so nothing is known about sustained use. This is a caution, not a failed result.

Typical dose

An extract standardised to 50–100 mg harpagoside daily (roughly 1–3 g of extract)

Upper limit: No established UL; trials rarely exceeded six weeks, so long-term dosing is untested

Timing

With food, standard dosing.

Time to effect

Weeks: Any reported joint comfort effect in studies.

Medication interactions

Warfarin and other anticoagulants: A case of purpura was reported on the combination; guidance advises against pairing them. (moderate)
Antiarrhythmic and heart-rate medication: Devil's claw may affect heart rhythm and is advised against alongside these drugs. (moderate)

Common myth

“Devil’s claw works as fast as over-the-counter pain relievers.” In reality: Its studied effects build gradually over weeks — not a fast-acting option.